Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Speciality Medicines Ltd. has filed a Draft Red Herring Prospectus (DRHP) with the exchange on August 21, 2024 to raise funds through Initial Public Offer (IPO).
Speciality Medicines Ltd. IPO is a Book Build Issue
The equity shares are proposed to be listed on the BSE SME. Ekadrisht Capital Pvt.Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Speciality Medicines IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | [.] to [.] per share |
| Lot Size | |
| Sale Type | Fresh Capital |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 64,35,796 shares |
| Share Holding Post Issue | 87,35,796 shares |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Size Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of Net Issue |
| NII Shares Offered | Not less than 15% of Net Issue |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Wed, Aug 21, 2024 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals — including high-cost oral and injectable medications used to treat complex chronic conditions — across both domestic and international markets.
The company’s portfolio includes a wide range of speciality pharmaceutical finished formulations such as capsules, creams, eye drops, gels, infusions, inhalations and inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, oral suspensions, sachets, suspensions, and tablets.
Through wide-ranging distribution channels, the company has built a trusted reputation with clients across more than 20 states in India and over 35 countries worldwide.
Speciality Medicines Limited offers over 650 products (as of July 31, 2024) under the unregistered category, with a particular focus on therapeutic areas like:
Additionally, the company’s product range includes human and animal medicines, vaccines, and plasma products — all sourced from manufacturers that comply with global quality standards like EUGMP and PICS.
Global Expansion and Registrations
As of July 31, 2024, Speciality Medicines Limited has:
As of July 31, 2024, Speciality Medicines Limited employs a team of 20 permanent employees across various departments, contributing to the company’s smooth and efficient operations.
| Period Ended | 31 May 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 26.44 | 23.43 | 13.26 | 5.78 |
| Total Income | 8.37 | 27.66 | 23.26 | 40.45 |
| Profit After Tax | 2.3 | 4.55 | 1.69 | 1.48 |
| Net Worth | 19.23 | 16.61 | 5.87 | 1.93 |
| Reserves and Surplus | 14.08 | 11.5 | 2.05 | 1.72 |
| Total Borrowing | 2.53 | 2.86 | 3.64 | 1.18 |
| Amount in ₹ Crore | ||||
| KPI | Values |
|---|---|
| ROE | 40.44% |
| ROCE | 34.95% |
| Debt/Equity | 0.17 |
| RoNW | 27.36% |
| PAT Margin | 16.52% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 7.06 | 15.79 |
Speciality Medicines Ltd.
913, One World West, S. No. 396, FP 119,
Village- Vejalpur, Ahmadabad City,
Ahmedabad, Gujarat, India,
Ahmedabad, Gujarat, 380051
Phone: +91 22 4604 5344
Email: investors.grievances@specialitymedicine.com
Website: http://www.specialitymedicine.com/
Skyline Financial Services Pvt.Ltd.
Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php
Speciality Medicines IPO is a SME IPO of 0 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at . The minimum order quantity is .
The Speciality Medicines IPO open and close dates are not available as of now.
Skyline Financial Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Speciality Medicines IPO using UPI as a payment gateway. Zerodha customers can apply in Speciality Medicines IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Speciality Medicines IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Speciality Medicines IPO dates are not announced. Please check back again after some time.
Speciality Medicines IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Speciality Medicines IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Speciality Medicines IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Speciality Medicines IPO allotment status.
The Speciality Medicines IPO listing date is not yet announced. The tentative date of Speciality Medicines IPO listing is [.].
Useful Articles
